298
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Role of Ethnicity in Antipsychotic-Induced Weight Gain and Tardive Dyskinesia: Genes or Environment?

, , , , , , , & show all
Pages 1273-1281 | Received 17 Jun 2013, Published online: 09 Aug 2013

References

  • Mackenzie B , SouzaRP, LikhodiO et al. Pharmacogenetics of antipsychotic treatment response and side effects. Therapy 7(2) , 191–198 (2010).
  • Holt RIG , PevelerRC. Obesity, serious mental illness and antipsychotic drugs. Diabetes Obes. Metab.11 , 665–679 (2009).
  • Correll CU , Rummel-KlugeC, CorvesC, KaneJM, Leucht S. Antipsychotic combinations vs monotherapy in schizophrenia: a meta-analysis of randomized controlled trials. Schizophr. Bull.35(2) , 443–457 (2009).
  • Newcomer JW . Metabolic considerations in the use of antipsychotic medications: a review of recent evidence. J. Clin. Psychiatry68(Suppl. 1) , S20–S27 (2007).
  • Raedler TJ . Cardiovascular aspects of antipsychotics. Curr. Opin. Psychiatry23(6) , 574–581 (2010).
  • Müller DJ , ChowdhuryNI, ZaiCC. The pharmacogenetics of antipsychotic-induced adverse events. Curr. Opin. Psychiatry26(2) , 144–150 (2013).
  • Chaudhry IB , NeelamK, DudduV, HusainN. Ethnicity and psychopharmacology. J. Psychopharmacol.22(6) , 673–680 (2008).
  • Müller DJ , ZaiCC, SicardM et al. Systematic analysis of dopamine receptor genes (DRD1–DRD5) in antipsychotic-induced weight gain. Pharmacogenomics J. 12(2) , 156–164 (2012).
  • Jerrell JM . Adverse events associated with psychotropic treatment in African American children and adolescents. J. Natl Med. Assoc.102(5) , 375–383 (2010).
  • Stauffer VL , SniadeckiJL, PiezerKW et al. Impact of race on efficacy and safety during treatment with olanzapine in schizophrenia, schizophreniform or schizoaffective disorder. BMC Psychiatry 10 , 89 (2010).
  • Lipkovich I , JacobsonJG, CaldwellC, HoffmannVP, KryzhanovskayaL, BeasleyCM. Early predictors of weight gain risk during treatment with olanzapine: analysis of pooled data from 58 clinical trials. Psychopharmacol. Bull.42(4) , 23–39 (2009).
  • de Leon J , DiazFJ, JosiassenRC, CooperTB, SimpsonGM. Weight gain during a double-blind multidosage clozapine study. J. Clin. Psychopharmacol.27(1) , 22–27 (2007).
  • Tenback DE , HartenPN. Epidemiology and risk factors for (tardive) dyskinesia. Int. Rev. Neurobiol.98 , 211–230 (2011).
  • Ormerod S , McDowellSE, ColemanJJ, FernerRE. Ethnic differences in the risks of adverse reactions to drugs used in the treatment of psychoses and depression: a systematic review and meta-analysis. Drug Saf.31(7) , 597–607 (2008).
  • Teo C , BorlidoC, KennedyJL, De Luca V. The role of ethnicity in treatment refractory schizophrenia. Compr. Psychiatry54(2) , 167–172 (2013).
  • Kaufman JS , CooperRS. Commentary: considerations for use of racial/ethnic classification in etiologic research. Am. J. Epidemiol.154(4) , 291–298 (2001).
  • Lee YL , TeitelbaumS, WolffMS, WetmurJG, ChenJ. Comparing genetic ancestry and self-reported race/ethnicity in a multiethnic population in New York City. J. Genet.89(4) , 417–423 (2012).
  • Arranz MJ , KapurS. Pharmacogenetics in psychiatry: are we ready for widespread clinical use? Schizophr. Bull.1(34) , 1130–1144 (2008).
  • Masellis M , BasileV, MeltzerHY et al. Serotonin subtype 2 receptor genes and clinical response to clozapine in schizophrenia patients. Neuropsychopharmacology 19(2) , 123–132 (1998).
  • Volavka J , CzoborP, SheitmanB et al. Clozapine, olanzapine, risperidone, and haloperidol in the treatment of patients with chronic schizophrenia and schizoaffective disorder. Am. J. Psychiatry 159(2) , 255–262 (2002); erratum: 159(12) , 2132 (2002).
  • Basile VS , MasellisM, BadriF et al. Association of the MscI polymorphism of the dopamine D3 receptor gene with tardive dyskinesia in schizophrenia. Neuropsychopharmacology 21(1) , 17–27 (1999).
  • Zai CC , HwangRW, De Luca V et al. Association study of tardive dyskinesia and twelve DRD2 polymorphisms in schizophrenia patients. Int. J. Neuropsychopharmacol.10(5) , 639–651 (2007).
  • Lahiri DK , NurnbergerJI. A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies. Nucleic Acids Res.19(19) , 5444 (1991).
  • The International HapMap Consortium. The International HapMap Project. Nature426 , 789–796 (2003).
  • Hubisz MJ , FalD. Inferring weak population structure with the assistance of sample group information. Mol. Ecol. Resour.9 , 1322–1332 (2009).
  • He M , GitschierJ, ZerjalT, de Knijff P, Tyler-Smith C, Xue Y. Geographical affinities of the HapMap samples. PLoS ONE4(3) , e4684 (2009).
  • Price AL , PattersonNJ, PlengeRM, WeinblattME, ShadickNA, ReichD. Principal components analysis corrects for stratification in genome-wide association studies. Nat. Genet.38 , 904–909 (2006).
  • Liu XQ , PatersonAD, JohnEM, KnightJA. The role of self-defined race/ethnicity in population structure control. Ann. Hum. Genet.70 , 496–505 (2006).
  • Zhang Q , WangY. Trends in the association between obesity and socioeconomic status in U.S. adults: 1971 to 2000. Obes. Res.12 , 1622–1632 (2004).
  • Edwards TL , Velez Edwards DR, Villegas R et al. HTR1B, ADIPOR1, PPARGC1A, and CYP19A1 and obesity in a cohort of Caucasians and African Americans: an evaluation of gene–environment interactions and candidate genes. Am. J. Epidemiol.175(1) , 11–21 (2012).
  • Candib LM . Obesity and diabetes in vulnerable populations: reflection on proximal and distal causes. Ann. Fam. Med.5(6) , 547–556 (2007).
  • Caprio S , DanielsSR, DrewnowskiA et al. Influence of race, ethnicity, and culture on childhood obesity: implications for prevention and treatment. Obesity (Silver Spring) 2566–2577 (2008).
  • Lee SY , ParkMH, PatkarAA, PaeCU. A retrospective comparison of BMI changes and the potential risk factors among schizophrenic inpatients treated with aripiprazole, olanzapine, quetiapine or risperidone. Prog. Neuropsychopharmacol. Biol. Psychiatry35(2) , 490–496 (2011).
  • Gentile S . Contributing factors to weight gain during long-term treatment with second-generation antipsychotics. A systematic appraisal and clinical implications. Obes. Rev.10 , 527–542 (2009).
  • Sundram S , LambertT, PiskulicD. Acculturation is associated with the prevalence of tardive dyskinesia and akathisia in community-treated patients with schizophrenia. Acta Psychiatr. Scand.117(6) , 474–478 (2008).

▪ Website

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.